Skip to main content
PMC home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1973 Dec;46(5):681–692.

Studies of humoral and cell-mediated immunity in human melanoma.

B Mukherji, L Nathanson, D A Clark
PMCID: PMC2591996  PMID: 4130586

Full text

PDF
683

Images in this article

683Fig. 1
on p.683
689Fig. 2
on p.689

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bodenham D. C. A study of 650 observed malignant melanomas in the South-West region. Ann R Coll Surg Engl. 1968 Oct;43(4):218–239. [PMC free article] [PubMed] [Google Scholar]
  2. Bubeník J., Perlmann P., Helmstein K., Moberger G. Cellular and humoral immune responses to human urinary bladder carcinomas. Int J Cancer. 1970 May 15;5(3):310–319. doi: 10.1002/ijc.2910050303. [DOI] [PubMed] [Google Scholar]
  3. Clark D. A., Necheles T., Nathanson L., Silverman E. Apparent HL-A5 deficiency in malignant melanoma. Transplantation. 1973 Mar;15(3):326–328. doi: 10.1097/00007890-197303000-00010. [DOI] [PubMed] [Google Scholar]
  4. Cochran A. J., Jehn U. W., Gothoskar B. P. Cell-mediated immunity in malignant melanoma. Lancet. 1972 Jun 17;1(7764):1340–1341. doi: 10.1016/s0140-6736(72)91070-7. [DOI] [PubMed] [Google Scholar]
  5. Currie G. A., Lejeune F., Fairley G. H. Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma. Br Med J. 1971 May 8;2(5757):305–310. doi: 10.1136/bmj.2.5757.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. FOLEY E. J. Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin. Cancer Res. 1953 Dec;13(12):835–837. [PubMed] [Google Scholar]
  7. Fass L., Herberman R. B., Ziegler J. L., Kiryabwire J. W. Cutaneous hypersensitivity reactions to autologous extracts of malignant melanoma cells. Lancet. 1970 Jan 17;1(7638):116–118. doi: 10.1016/s0140-6736(70)90467-8. [DOI] [PubMed] [Google Scholar]
  8. GOLD P., FREEDMAN S. O. DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES. J Exp Med. 1965 Mar 1;121:439–462. doi: 10.1084/jem.121.3.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hellström I. E., Hellström K. E., Pierce G. E., Bill A. H. Demonstration of cell-bound and humoral immunity against neuroblastoma cells. Proc Natl Acad Sci U S A. 1968 Aug;60(4):1231–1238. doi: 10.1073/pnas.60.4.1231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hellström I., Hellström K. E., Pierce G. E., Yang J. P. Cellular and humoral immunity to different types of human neoplasms. Nature. 1968 Dec 28;220(5174):1352–1354. doi: 10.1038/2201352a0. [DOI] [PubMed] [Google Scholar]
  11. Hellström I., Hellström K. E., Sjögren H. O., Warner G. A. Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity. Int J Cancer. 1971 Sep 15;8(2):185–191. doi: 10.1002/ijc.2910080202. [DOI] [PubMed] [Google Scholar]
  12. Hellström I., Pierce G. E., Hellström K. E. Human tumor-specific antigens. Surgery. 1969 Jun;65(6):984–989. [PubMed] [Google Scholar]
  13. Hellström I., Sjögren H. O., Warner G., Hellström K. E. Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms. Int J Cancer. 1971 Mar 15;7(2):226–237. doi: 10.1002/ijc.2910070206. [DOI] [PubMed] [Google Scholar]
  14. Hellström K. E., Hellström I. Cellular immunity against tumor antigens. Adv Cancer Res. 1969;12:167–223. doi: 10.1016/s0065-230x(08)60331-0. [DOI] [PubMed] [Google Scholar]
  15. Henle G., Henle W. Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol. 1966 Mar;91(3):1248–1256. doi: 10.1128/jb.91.3.1248-1256.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jehn U. W., Nathanson L., Schwartz R. S., Skinner M. In vitro lymphocyte stimulation by a soluble antigen from malignant melanoma. N Engl J Med. 1970 Aug 13;283(7):329–333. doi: 10.1056/NEJM197008132830702. [DOI] [PubMed] [Google Scholar]
  17. Klein G., Clifford P., Klein E., Stjernswärd J. Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. Proc Natl Acad Sci U S A. 1966 Jun;55(6):1628–1635. doi: 10.1073/pnas.55.6.1628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Klein G. Tumor antigens. Annu Rev Microbiol. 1966;20:223–252. doi: 10.1146/annurev.mi.20.100166.001255. [DOI] [PubMed] [Google Scholar]
  19. Lewis M. G., Ikonopisov R. L., Nairn R. C., Phillips T. M., Fairley G. H., Bodenham D. C., Alexander P. Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease. Br Med J. 1969 Sep 6;3(5670):547–552. doi: 10.1136/bmj.3.5670.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lewis M. G. Possible immunological factors in human malignant melanoma in Uganda. Lancet. 1967 Oct 28;2(7522):921–922. doi: 10.1016/s0140-6736(67)90236-x. [DOI] [PubMed] [Google Scholar]
  21. Lloyd O. C. Regression of malignant melanoma as a manifestation of a cellular immunity response. Proc R Soc Med. 1969 Jun;62(6):543–545. [PMC free article] [PubMed] [Google Scholar]
  22. Morton D. L., Malmgren R. A., Holmes E. C., Ketcham A. S. Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery. 1968 Jul;64(1):233–240. [PubMed] [Google Scholar]
  23. Morton D. L., Malmgren R. A. Human osteosarcomas: immunologic evidence suggesting an associated infectious agent. Science. 1968 Dec 13;162(3859):1279–1281. doi: 10.1126/science.162.3859.1279. [DOI] [PubMed] [Google Scholar]
  24. Morton D. L. Recent advances in oncology. Ann Intern Med. 1972 Sep;77(3):431–454. doi: 10.7326/0003-4819-77-3-431. [DOI] [PubMed] [Google Scholar]
  25. OLD L. J., BOYSE E. A. IMMUNOLOGY OF EXPERIMENTAL TUMORS. Annu Rev Med. 1964;15:167–186. doi: 10.1146/annurev.me.15.020164.001123. [DOI] [PubMed] [Google Scholar]
  26. Oettgen H. F., Aoki T., Old L. J., Boyse E. A., de Harven E., Mills G. M. Suspension culture of a pigment-producing cell line derived from a human malignant melanoma. J Natl Cancer Inst. 1968 Oct;41(4):827–843. [PubMed] [Google Scholar]
  27. Oettgen H. F., Bean M. A., Klein G. Workshop in human tumor immunology. Cancer Res. 1972 Dec;32(12):2845–2853. [PubMed] [Google Scholar]
  28. Oettgen H. F., Old L. J., Boyse E. A. Human tumor immunology. Med Clin North Am. 1971 May;55(3):761–785. doi: 10.1016/s0025-7125(16)32516-0. [DOI] [PubMed] [Google Scholar]
  29. Oettgen H. F., Old L. J., McLean E. P., Carswell E. A. Delayed hypersensitivity and transplantation immunity elicited by soluble antigens of chemically induced tumours in inbred guinea-pigs. Nature. 1968 Oct 19;220(5164):295–297. doi: 10.1038/220295a0. [DOI] [PubMed] [Google Scholar]
  30. Old L. J., Boyse E. A., Geering G., Oettgen H. F. Serologic approaches to the study of cancer in animals and in man. Cancer Res. 1968 Jul;28(7):1288–1299. [PubMed] [Google Scholar]
  31. PREHN R. T., MAIN J. M. Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst. 1957 Jun;18(6):769–778. [PubMed] [Google Scholar]
  32. Romsdahl M. M., Cox I. S. Human malignant melanoma antibodies demonstrated by immunofluorescence. Arch Surg. 1970 Apr;100(4):491–497. doi: 10.1001/archsurg.1970.01340220167028. [DOI] [PubMed] [Google Scholar]
  33. SMITHERS D. W. Spontaneous regression of tumours. Clin Radiol. 1962 Apr;13:132–137. doi: 10.1016/s0009-9260(62)80034-8. [DOI] [PubMed] [Google Scholar]
  34. Smith J. L., Jr, Stehlin J. S., Jr Spontaneous regression of primary malignant melanomas with regional metastases. Cancer. 1965 Nov;18(11):1399–1415. doi: 10.1002/1097-0142(196511)18:11<1399::aid-cncr2820181104>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  35. Southam C. M. Evidence of immunological reactions to autochthonous cancer in man. Eur J Cancer. 1965 Nov;1(3):173–181. doi: 10.1016/0014-2964(65)90045-9. [DOI] [PubMed] [Google Scholar]
  36. Ziegler J. L., Lewis M. G., Luyombya J. M., Kiryabwire J. W. Immunologic studies in patients with malignant melanoma in Uganda. Br J Cancer. 1969 Dec;23(4):729–734. doi: 10.1038/bjc.1969.89. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES